Carlos Javier Almeciga-Diaz
Overview
Explore the profile of Carlos Javier Almeciga-Diaz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
163
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Villada-Troncoso S, Arevalo-Romero J, Hernandez Rivera V, Pedraza-Escalona M, Perez-Tapia S, Espejo-Mojica A, et al.
Pharmaceuticals (Basel)
. 2024 Sep;
17(9).
PMID: 39338402
Background/objectives: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, was declared a public health emergency in early 2020. The infection initiates when the receptor-binding domain (RBD)...
2.
3.
Losada J, Triana H, Vanegas E, Caro A, Rodriguez-Lopez A, Espejo-Mojica A, et al.
Chembiochem
. 2024 Jun;
25(15):e202400081.
PMID: 38830828
Mucopolysaccharidosis type IIIB (MPS IIIB) is an autosomal inherited disease caused by mutations in gene encoding the lysosomal enzyme N-acetyl-alpha-glucosaminidase (NAGLU). These mutations result in reduced NAGLU activity, preventing it...
4.
Arevalo-Romero J, Chingate-Lopez S, Camacho B, Almeciga-Diaz C, Ramirez-Segura C
Heliyon
. 2024 Mar;
10(5):e26423.
PMID: 38434363
The COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), emerged in 2019 following prior outbreaks of coronaviruses like SARS and MERS in recent decades, underscoring their high...
5.
Ramirez C, Almeciga-Diaz C, Martin-Rufian M, Cardenas-Garcia C, Espejo-Mojica A, Lobo C, et al.
Biochem Biophys Res Commun
. 2024 Jan;
696:149490.
PMID: 38241811
The Lysosomal Storage disease known as Mucopolysaccharidosis type II, is caused by mutations affecting the iduronate-2-sulfatase required for heparan and dermatan sulfate catabolism. The central nervous system (CNS) is mostly...
6.
Leal A, Celik B, Fnu N, Khan S, Tomatsu S, Almeciga-Diaz C
Mol Ther Methods Clin Dev
. 2023 Dec;
31:101153.
PMID: 38107675
Mucopolysaccharidosis (MPS) IVA is a lysosomal storage disorder caused by mutations in the gene that leads to the lysosomal accumulation of keratan sulfate (KS) and chondroitin 6-sulfate, causing skeletal dysplasia...
7.
Leal A, Almeciga-Diaz C, Tomatsu S
Int J Mol Sci
. 2023 Nov;
24(22).
PMID: 38003337
Mucopolysaccharidosis IVA (MPS IVA) is a rare disorder caused by mutations in the N-acetylgalactosamine-6-sulfate-sulfatase () encoding gene. GALNS leads to the lysosomal degradation of the glycosaminoglyccreasans keratan sulfate and chondroitin...
8.
Leal A, Inci O, Seyrantepe V, Rintz E, Celik B, Ago Y, et al.
Mol Genet Metab
. 2023 Aug;
140(3):107648.
PMID: 37598508
Lysosomal storage diseases (LSDs) are caused by monogenic mutations in genes encoding for proteins related to the lysosomal function. Lysosome plays critical roles in molecule degradation and cell signaling through...
9.
Quintero Barbosa J, Almeciga-Diaz C, Perez S, Gutierrez M
Vaccines (Basel)
. 2023 Jul;
11(7).
PMID: 37514988
Infectious bovine rhinotracheitis (IBR) and bovine meningoencephalitis are caused by (BoHV) types 1 and 5, which seriously threaten the global cattle industry. Vaccination to improve immunity is the most direct...
10.
Leal A, Benincore-Florez E, Rintz E, Herreno-Pachon A, Celik B, Ago Y, et al.
Int J Mol Sci
. 2023 Jan;
24(1).
PMID: 36613919
Mucopolysaccharidoses (MPSs) constitute a heterogeneous group of lysosomal storage disorders characterized by the lysosomal accumulation of glycosaminoglycans (GAGs). Although lysosomal dysfunction is mainly affected, several cellular organelles such as mitochondria,...